BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 20058238)

  • 1. Prostate-specific antigen (PSA) is activated by KLK2 in prostate cancer ex vivo models and in prostate-targeted PSA/KLK2 double transgenic mice.
    Williams SA; Xu Y; De Marzo AM; Isaacs JT; Denmeade SR
    Prostate; 2010 May; 70(7):788-96. PubMed ID: 20058238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduced KLK2 expression is a strong and independent predictor of poor prognosis in ERG-negative prostate cancer.
    Bonk S; Kluth M; Jansen K; Hube-Magg C; Makrypidi-Fraune G; Höflmayer D; Weidemann S; Möller K; Uhlig R; Büscheck F; Luebke AM; Burandt E; Clauditz TS; Steurer S; Schlomm T; Huland H; Heinzer H; Sauter G; Simon R; Dum D
    Prostate; 2020 Sep; 80(13):1097-1107. PubMed ID: 32628300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identifying the combination of the transcriptional regulatory sequences on prostate specific antigen and human glandular kallikrein genes.
    Tsui KH; Wu L; Chang PL; Hsieh ML; Juang HH
    J Urol; 2004 Nov; 172(5 Pt 1):2029-34. PubMed ID: 15540783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models.
    Denmeade SR; Sokoll LJ; Dalrymple S; Rosen DM; Gady AM; Bruzek D; Ricklis RM; Isaacs JT
    Prostate; 2003 Mar; 54(4):249-57. PubMed ID: 12539223
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human kallikrein 2 (hK2), but not prostate-specific antigen (PSA), rapidly complexes with protease inhibitor 6 (PI-6) released from prostate carcinoma cells.
    Saedi MS; Zhu Z; Marker K; Liu RS; Carpenter PM; Rittenhouse H; Mikolajczyk SD
    Int J Cancer; 2001 Nov; 94(4):558-63. PubMed ID: 11745444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans.
    Cleutjens KB; van der Korput HA; Ehren-van Eekelen CC; Sikes RA; Fasciana C; Chung LW; Trapman J
    Mol Endocrinol; 1997 Aug; 11(9):1256-65. PubMed ID: 9259317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated levels of prostate-specific antigen (PSA) in prostate cancer cells expressing mutant p53 is associated with tumor metastasis.
    Downing S; Bumak C; Nixdorf S; Ow K; Russell P; Jackson P
    Mol Carcinog; 2003 Nov; 38(3):130-40. PubMed ID: 14587098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostate-specific kallikrein-related peptidases and their relation to prostate cancer biology and detection. Established relevance and emerging roles.
    Thorek DL; Evans MJ; Carlsson SV; Ulmert D; Lilja H
    Thromb Haemost; 2013 Sep; 110(3):484-92. PubMed ID: 23903407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic variation in KLK2 and KLK3 is associated with concentrations of hK2 and PSA in serum and seminal plasma in young men.
    Sävblom C; Halldén C; Cronin AM; Säll T; Savage C; Vertosick EA; Klein RJ; Giwercman A; Lilja H
    Clin Chem; 2014 Mar; 60(3):490-9. PubMed ID: 24270797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells.
    Veveris-Lowe TL; Lawrence MG; Collard RL; Bui L; Herington AC; Nicol DL; Clements JA
    Endocr Relat Cancer; 2005 Sep; 12(3):631-43. PubMed ID: 16172196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human tissue Kallikreins: Blood levels and response to radiotherapy in intermediate risk prostate cancer.
    Nasser NJ; Thoms J; Soosaipillai A; Pintilie M; Wang R; Diamandis EP; Bristow RG
    Radiother Oncol; 2017 Sep; 124(3):427-432. PubMed ID: 28427756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of combined "triple"-reverse transcription-PCR analysis for prostate-specific antigen, human kallikrein 2, and prostate-specific membrane antigen mRNA in peripheral blood and lymph nodes of prostate cancer patients.
    Kurek R; Nunez G; Tselis N; Konrad L; Martin T; Roeddiger S; Aumüller G; Zamboglou N; Lin DW; Tunn UW; Renneberg H
    Clin Cancer Res; 2004 Sep; 10(17):5808-14. PubMed ID: 15355910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation.
    Shang Z; Niu Y; Cai Q; Chen J; Tian J; Yeh S; Lai KP; Chang C
    Tumour Biol; 2014 Mar; 35(3):1881-90. PubMed ID: 24122203
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatically active prostate-specific antigen promotes growth of human prostate cancers.
    Williams SA; Jelinek CA; Litvinov I; Cotter RJ; Isaacs JT; Denmeade SR
    Prostate; 2011 Nov; 71(15):1595-607. PubMed ID: 21394741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relative concentrations of hK2/PSA mRNA in benign and malignant prostatic tissue.
    Lintula S; Stenman J; Bjartell A; Nordling S; Stenman UH
    Prostate; 2005 Jun; 63(4):324-9. PubMed ID: 15599939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased concentrations of prostate-specific antigen and human glandular kallikrein 2 in malignant versus nonmalignant prostatic tissue.
    Magklara A; Scorilas A; Stephan C; Kristiansen GO; Hauptmann S; Jung K; Diamandis EP
    Urology; 2000 Sep; 56(3):527-32. PubMed ID: 10962338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Murine, but not human, ephrin-B2 can be efficiently cleaved by the serine protease kallikrein-4: implications for xenograft models of human prostate cancer.
    Lisle JE; Mertens-Walker I; Stephens CR; Stansfield SH; Clements JA; Herington AC; Stephenson SA
    Exp Cell Res; 2015 Apr; 333(1):136-46. PubMed ID: 25724897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kallikrein gene expression in human pituitary tissues.
    Clements JA; Mukhtar A; Verity K; Pullar M; McNeill P; Cummins J; Fuller PJ
    Clin Endocrinol (Oxf); 1996 Feb; 44(2):223-31. PubMed ID: 8849579
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Localization of a new prostate-specific antigen-related serine protease gene, KLK4, is evidence for an expanded human kallikrein gene family cluster on chromosome 19q13.3-13.4.
    Stephenson SA; Verity K; Ashworth LK; Clements JA
    J Biol Chem; 1999 Aug; 274(33):23210-4. PubMed ID: 10438493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.